- Home
- SFST vs CADL Comparison
SFST vs CADL Comparison
Compare SFST & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFST
- CADL
- Stock Information
- Founded
- SFST 1999
- CADL 1999
- Country
- SFST United States
- CADL United States
- Employees
- SFST N/A
- CADL N/A
- Industry
- SFST Major Banks
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- SFST Finance
- CADL Health Care
- Exchange
- SFST Nasdaq
- CADL Nasdaq
- Market Cap
- SFST 335.4M
- CADL 313.5M
- IPO Year
- SFST 1999
- CADL 2021
- Fundamental
- Price
- SFST $45.21
- CADL $4.81
- Analyst Decision
- SFST Buy
- CADL Strong Buy
- Analyst Count
- SFST 1
- CADL 5
- Target Price
- SFST $51.00
- CADL $19.80
- AVG Volume (30 Days)
- SFST 18.9K
- CADL 735.7K
- Earning Date
- SFST 10-21-2025
- CADL 08-14-2025
- Dividend Yield
- SFST N/A
- CADL N/A
- EPS Growth
- SFST 58.48
- CADL N/A
- EPS
- SFST 2.69
- CADL N/A
- Revenue
- SFST $102,878,000.00
- CADL N/A
- Revenue This Year
- SFST $8.65
- CADL N/A
- Revenue Next Year
- SFST $13.43
- CADL N/A
- P/E Ratio
- SFST $16.53
- CADL N/A
- Revenue Growth
- SFST 15.60
- CADL N/A
- 52 Week Low
- SFST $29.14
- CADL $3.79
- 52 Week High
- SFST $46.00
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- SFST 60.20
- CADL 33.41
- Support Level
- SFST $44.13
- CADL $4.81
- Resistance Level
- SFST $45.36
- CADL $5.01
- Average True Range (ATR)
- SFST 0.85
- CADL 0.30
- MACD
- SFST -0.07
- CADL -0.08
- Stochastic Oscillator
- SFST 64.14
- CADL 5.30
About SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.